Abeona Therapeutics Incis A Clinical Stage Biopharmaceutical Company Based In Clevelandohiothe Company Specializes In Developing Cell And Gene Therapies For Life Threatening Diseasesparticularly Targeting Rare Genetic Disorderswith A Dedicated Team Of Approximately 136 Employeesabeona Operates A Cgmp Manufacturing Facility To Support Its Clinical And Potential Commercial Production Abeona S Product Pipeline Includes Innovative Therapies Such As Pz Celan Engineered Cell Therapy For Recessive Dystrophic Epidermolysis Bullosaand Eb 101A Gene Corrected Cell Therapy For The Same Conditionthe Company Also Develops Aav Based Gene Therapies Targeting Various Retinal Disordersincluding Abo 503 For X Linked Retinoschisis And Abo 504 For Stargardt Diseaseadditionallyabeona Utilizes The Aim Vector Platform To Enhance Gene Therapy Deliverythe Company Collaborates With Partners Like Ultragenyx Pharmaceutical And Taysha Gene Therapies To Advance Its Therapeutic Offerings
